Innogest Capital

Founded in 2007, Innogest Capital is a Milan-based early-stage VC, with offices in Turin, Geneva and San Francisco, managing over EUR 150M across funds focused on technology and life sciences. The firm invests EUR 0.5-5M at Series A in digital platforms, IoT, healthcare, and industrial tech. Notable portfolio companies include Genenta Science (IPO on Nasdaq), Musement (acquired by TUI), and Pharmacell. Innogest is one of Italy's pioneer independent VC firms with deep networks in the Piedmont and Lombardy tech ecosystems.